Jonathan L. Halperin

92.3k citations
391 papers · 71.5k · 39 hit papers · h-index 120

Impact in

    • Venous Thromboembolism Diagnosis and Management
    • Atrial Fibrillation Management and Outcomes
    • Cardiac Arrhythmias and Treatments
    • Antiplatelet Therapy and Cardiovascular Diseases
    • Acute Myocardial Infarction Research
    • Cardiac electrophysiology and arrhythmias

Papers in

    • Atrial Fibrillation Management and Outcomes 234
    • Cardiac Arrhythmias and Treatments 68
    • Antiplatelet Therapy and Cardiovascular Diseases 38
    • Cardiac electrophysiology and arrhythmias 23
    • Cardiac pacing and defibrillation studies 22
    • Venous Thromboembolism Diagnosis and Management 56

Jonathan L. Halperin

385 papers receiving 66.9k citations

Jonathan L. Halperin's Hit Papers

Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex 2022 · 257 citations
2570+5+10Years since publication2505007501000

Peers

Jonathan L. Halperin
Comparison fields: 5 of 192
  • Internal Medicine 8.4k
  • Cardiology and Cardiovascular Medicine 49.5k
  • Radiology, Nuclear Medicine and Imaging 5.5k
  • Surgery 9.7k
  • Pulmonary and Respiratory Medicine 6.1k
Replace Lars C. Wallentin with:
Lars C. Wallentin Sweden
Christian Funck‐Brentano France
Stuart J. Connolly Canada
Juan Luis Tamargo Spain
Kenneth Mahaffey United States
Paulus F. Kirchhof Germany
A. John Camm United Kingdom
Basil S. Lewis Israel
John W. Eikelboom Canada
Eugene Braunwald United States
Jonathan L. Halperin relative to Lars C. Wallentin Sweden Lars C. Wallentin's profile →
Citations per field
00.5×1.5×2.0×
Lars C. Wallentin · 1×
Citations per year

Countries citing papers authored by Jonathan L. Halperin

Since Specialization
Citations

This map shows the geographic impact of Jonathan L. Halperin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan L. Halperin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan L. Halperin more than expected).

Fields of papers citing papers by Jonathan L. Halperin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan L. Halperin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan L. Halperin. The network helps show where Jonathan L. Halperin may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan L. Halperin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan L. Halperin Line = papers co-authored together Jonathan L. Halperin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 391 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Hit paper breakdown →
20117437
2
ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary
Hit paper breakdown →
20046873
3
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Hit paper breakdown →
20062369
4
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hit paper breakdown →
20051932
5
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article
Hit paper breakdown →
20061868
6
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Hit paper breakdown →
20061529
7
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
Hit paper breakdown →
20061489
8
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
Hit paper breakdown →
20061375
9
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
Hit paper breakdown →
20101229
10
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
Hit paper breakdown →
20161155
11
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
Hit paper breakdown →
20011123
12
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
Hit paper breakdown →
20071086
13
ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
Hit paper breakdown →
20041084
14
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
Hit paper breakdown →
2006922
15
Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
Hit paper breakdown →
2010863
16
ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary
Hit paper breakdown →
2004838
17
ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary A Collaborative Report From the American Association for Vascular Surgery/Society for Vascular Surgery,⁎⁎AAVS/SVS when Guideline initiated, now merged into SVSSociety for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease)
Hit paper breakdown →
2006808
18
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Hit paper breakdown →
2011787
19
2014 AHA/ACC guideline for the management of patients with valvular heart disease
Hit paper breakdown →
2014773
20
Antithrombotic Therapy for Atrial Fibrillation
Hit paper breakdown →
2012758

About Jonathan L. Halperin

Jonathan L. Halperin is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Pulmonary and Respiratory Medicine, having authored 391 papers that have together received 71.5k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (234 papers), Cardiac Arrhythmias and Treatments (68 papers), Venous Thromboembolism Diagnosis and Management (56 papers), Antiplatelet Therapy and Cardiovascular Diseases (38 papers), Cardiac Imaging and Diagnostics (35 papers), Cardiac electrophysiology and arrhythmias (23 papers), Health Systems, Economic Evaluations, Quality of Life (23 papers) and Cardiac pacing and defibrillation studies (22 papers). The work is most often cited by research in Internal Medicine (8.4k citations), Cardiology and Cardiovascular Medicine (49.5k citations), Radiology, Nuclear Medicine and Imaging (5.5k citations), Surgery (9.7k citations) and Pulmonary and Respiratory Medicine (6.1k citations). Jonathan L. Halperin has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Daniel E. Singer, Keith A.A. Fox, Jonathan Paul Piccini, Valentı́n Fuster, Kenneth Mahaffey, Manesh R. Patel, Christopher C. Nessel, Graeme J. Hankey, Gregory Y.H. Lip and Richard C. Becker. Their work appears in journals such as Journal of the American College of Cardiology, Circulation, American Heart Journal, European Heart Journal and The American Journal of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact